R&D Systems Human CEACAM-19 Fc Chimera Recombinant Protein, Carrier-Free
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9397CM050
DescriptionThe Recombinant Human CEACAM-19 Fc Chimera Protein is derived from HEK293. The Recombinant Human CEACAM-19 Fc Chimera Protein has been validated for the following applications: Bioactivity.
Ships at ambient temperature.
|Lyophilized from a 0.2μm filtered solution in PBS|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|<0.10 EU per 1μg of the protein by the LAL method|
|0.4 to 2.4μg/mL|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.|
|carcinoembryonic antigen-related cell adhesion molecule 19, CEACAM19, CEAL1|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok
For Research Use Only.